Corey S Goodman bought ALXO once, on Feb 2, 2026
Director and 10% owner at ALX Oncology Holdings Inc.
SEC CIK 0001278411 · Filings on SEC.gov ↗
Corey S Goodman's record
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Every filing
1 filing since Feb 2026, newest first
About Corey S Goodman
Corey S. Goodman, Ph.D. is a prominent biopharmaceutical executive and venture capitalist, serving as co-founder, non-executive Chairman of the Board, and Director of ALX Oncology Holdings Inc. (NASDAQ: ALXO) since March 2015, previously as Executive Chairman until July 2024.( At age 73, he holds a significant beneficial ownership stake of approximately 9,967,494 shares (18.6% of outstanding stock), including shares controlled through venBio-affiliated entities, and recently oversaw a major purchase of 3,184,713 shares on February 2, 2026, at $1.57 per share via venBio Global Strategic Fund II, L.P., increasing holdings to 8,453,038 shares.(
Dr. Goodman is Co-founder and Managing Partner at venBio Partners since March 2010, focusing on life sciences investments, and previously founded Labrys Biologics (acquired by Teva in 2014).( A distinguished neuroscientist, he is a member of the U.S. National Academy of Sciences, American Academy of Arts & Sciences, and American Philosophical Society, and received the 2020 Gruber Neuroscience Prize.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.